
Keywords: Kidney; Stem cells; Regenerative medicine; Bcl2; B-cell lymphoma 2; CD10; neprilysin; CD15; 3-fucosyl-N-acetyl-lactosamine; CD133; prominin 1; CKD; chronic kidney disease; CK7; cytokeratin 7; CK8-18; cytokeratin 8-18; EMA (MUC1); anti-endomysial (mucin 1)